CoChat

Advancing the beneficial use of machine learning in health care and medicine: Toward a community understanding

Open access
Nevin, Linda, on behalf of the PLOS Medicine Editors · 2018 · PLOS Medicine
Cited by 58

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Due to the abundance of health data and growing computational power, machine learning (ML) is engaging health researchers in a process of discovery around developing data-driven algorithms to make clinically reliable predictions.ML has the potential to provide effective tools to improve outcomes and reduce costs in health care, and the clinical community should partake in developing and evaluating these discoveries.However, if misguided applications are to be avoided, methodological savvy will be needed to develop, interpret and implement ML in medicine [1,2].In preparing PLOS Medicine's Special Issue (SI) on Machine Learning in Health and Biomedicine, Guest Editors Atul Butte, Suchi Saria, and Aziz Sheikh, and the PLOS Medicine Editors, have identified two principles in the design and reporting of ML studies that we believe should guide researchers in advancing the beneficial use of ML in healthcare and medicine.These principles, which also inform PLOS Medicine's editorial priorities for manuscript submissions in this field, require first, that models derived through ML are demonstrably fit for their stated clinical purpose, and second, that researchers undertake and report appropriate efforts to validate these models in external datasets. Fit-for-purpose performanceAn ML model need not be ready for off-the-shelf, practice-changing implementation to make a valuable contribution, but must achieve a clear purpose.The current SI includes reports on ML approaches that have undergone retrospective validation and are now ready for prospective testing, ML at early stages of validation, and head-to-head comparisons between standard epidemiological and ML approaches that suggest future directions without themselves establishing clinical utility.The articles vary widely in the intended application or "use cases" for their models.In a study from Soo-Jin Kang and colleagues, ML deploying imaging data from intravascular coronary angiography was used to diagnose coronary ischemia without a more invasive measurement-fractional flow reserve-that is currently the diagnostic standard [3].The authors were not trying to challenge the standard of care, but to improve diagnosis when resource constraints or clinical indications make fractional flow reserve impractical or unsuitable.For applications intended to provide pragmatic options for nonideal circumstances, model performance can be benchmarked against current practice rather than recommended practice, as long as the limitations of the advance are clear to readers.Early research planning should consider clinically acceptable performance characteristics for the targeted application, and a clear description of its intended use-and inappropriate

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1002708

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 58

Metadata

Authors
Nevin, L., & Editors, O. B. O. T. P. M.
Venue
PLOS Medicine
Published
2018-11-30
Volume
15
Issue
11
Pages
e1002708
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W2902239438
Cited by
58
References
4
FWCI
1.09
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advancing the beneficial use of machine learning in health care and medicine: Toward a community understanding. https://app.cochat.ai/papers/10.1371/journal.pmed.1002708
The paper
Nevin, L., & Editors, O. B. O. T. P. M. (2018). Advancing the beneficial use of machine learning in health care and medicine: Toward a community understanding. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1002708

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.